Safinamide
CHF 49.50
Auf Lager
SKU
AVF2L23VOME
1 Verfügbar 
Kostenloser Versand ab CHF 50
Geliefert zwischen Do., 06.11.2025 und Fr., 07.11.2025
Details
High Quality Content by WIKIPEDIA articles! Safinamide is a candidate drug against Alzheimer's disease with multiple methods of action. In 2007, a Phase III clinical trial (Motion: Safinamide add-on to dopamine agonist for early idiopathic Parkinson's disease) was started. It will be marketed by Merck-Serono. Possible additional uses are restless legs syndrome (RLS) and epilepsy. As of 2008, they are in Phase II. Safinamide is a monoamine oxidase B inhibitor, reducing degradation of dopamine. It is a glutamate release inhibitor. It seems to inhibit dopamine reuptake.
30 Tage Rückgaberecht
GarantieWeitere Informationen
- Allgemeine Informationen
- GTIN 09786131355684
- Editor Lambert M. Surhone, Mariam T. Tennoe, Susan F. Henssonow
- EAN 9786131355684
- Titel Safinamide
- Herausgeber Betascript Publishing
- Anzahl Seiten 120
- Genre Mathematik
Bewertungen
Schreiben Sie eine Bewertung
